Alternate Health

Alternate Health FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Alternate Health (AHGIF) as of Nov 19, 2026 is 48.71 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 30.24 % — a change of 61.07% (higher).

FCF Conversion

48.71 %

YoY

61.07%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Alternate Health is 2018 48.71 % . FCF Conversion Rate (FCF/EBITDA) of Alternate Health was 2017 30.24 % . It decreases by 61.07% higher compared to the previous year.

The Alternate Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2016
65.97 CAD
Jan 1, 2017
30.24 CAD
Jan 1, 2018
48.71 CAD
The Alternate Health FCF Conversion history
YEARFCF ConversionYoY
48.71 %+61.07%
30.24 %-54.16%
65.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alternate Health Stock analysis

What does Alternate Health do? Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms. The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research. Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs. Alternate Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alternate Health stock

FCF Conversion Rate (FCF/EBITDA) of Alternate Health is 48.71 % in 2018.

FCF Conversion Rate (FCF/EBITDA) of Alternate Health changed from 30.24 % to 48.71 %, representing a 61.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Alternate Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Alternate Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Alternate Health

All Key Metrics — Alternate Health